Screener
Supernus Pharmaceuticals SUPN Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Supernus Pharmaceuticals’s reported figures.
The source filing: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356576-26-000022
FAQ
- What is Supernus Pharmaceuticals's free cash flow?
- Supernus Pharmaceuticals (SUPN) reported free cash flow of $66.52M in Q1 2026.
- How has Supernus Pharmaceuticals's free cash flow changed year-over-year?
- Supernus Pharmaceuticals's free cash flow increased by 119.8% year-over-year, from $30.27M to $66.52M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Supernus Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude